Loading...
Rhode Island Hospital / University of Rhode Island - PGY-2 Oncology Pharmacy Residency Program
Rhode Island Hospital
The American Society of Health-System Pharmacists (ASHP) accreditation standard provides criteria that every program must meet in order to receive and maintain accreditation. This program follows the ASHP-approved postgraduate year 2 (PGY2) oncology competency areas, goals and objectives. The requirement for this residency program is successful completion of a postgraduate year 1 (PGY1) residency. While this program follows ASHP standards, the strength of this program is its flexibility: it can be tailored to meet the needs and interests of the individual resident. The mission of our program includes developing a core skill set in hematology/oncology pharmacology, patient care and professional practice. Program graduates will be prepared to function independently as hematology/oncology clinical pharmacy specialists and act as an essential member of an interdisciplinary team caring for patients with cancer. Further, graduates will be prepared to function as adjunct faculty for pharmacy students on rotation and in classroom learning experiences at the College of Pharmacy. Finally, the graduate will be prepared for board certification in oncology pharmacy. PGY-2 Program Details
|
Requirements: PharmD degree, eligibility for RI licensure, completion of pharmacy practice residency (PGY-1), personal on-site interview, letter of intent, three letters of recommendation, and one example of a project (e.g. case presentation with discussion, drug use evaluation, didactic lecture, etc.) completed during PGY-1 residency program. |
Error